Asia-Pacific Pancreatic Cancer Therapeutics Market: By Treatment Type (Surgery, Chemotherapy, Radiation Therapy, Others), By Type (Exocrine Pancreas Cancer, Endocrine Pancreas Cancer), By End Users (Hospitals, Clinics, Research Institutes, Others), by Region – Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Asia-Pacific Pancreatic Cancer Therapeutics Market: By Treatment Type (Surgery, Chemotherapy, Radiation Therapy, Others), By Type (Exocrine Pancreas Cancer, Endocrine Pancreas Cancer), By End Users (Hospitals, Clinics, Research Institutes, Others), by Region – Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1280 | Pages: 179 | May 2017 | Region: Asia Pacific


Asia-Pacific Pancreatic Cancer was worth $ 0.33 billion in 2016 and estimated to be growing at a CAGR of 8.5 %, to reach $ 0.5 billion by 2021. Pancreatic cancer is caused by the uncontrolled growth of cells in the pancreas. This abnormal, unrestrained growth of cells results in the formation of lumps of tissue, widely referred to as tumors. The presence of tumors prevents the normal functioning of pancreas. The occurrence and mortality rate of pancreatic cancer is more in men than in women. It is the ninth leading cause of cancer death in Asia.

Cancer starts when cells in the body begin to grow beyond control. Pancreatic cancer starts when cells in the pancreas start to grow incessantly eventually resulting in symptoms like abdominal pain, weight loss, diarrhea, and jaundice. Apart from lifestyle dependent factors like alcohol consumption, obesity and smoking, a personal or family history of pancreatitis or old age may result in a person being affected by pancreatic cancer.

Given the insuppressible nature of pancreatic cancer, treatments often return insufficient results. This challenge is yet another barrier to the growth of this market. Technologies are yet to develop fully for the timely diagnosis of this cancer type, which results in the diagnosis of majority of pancreatic cancer patients at an advanced stage of the disease. This explains the high mortality rates associated with pancreatic cancer. Estimates show that only a small percentage, that is about 12% to 15% of the patients is diagnosed early enough to be treated with surgical procedures, drugs, and chemotherapy.

Based on the type of treatment, the market has been classified into surgery, chemotherapy, radiation therapy and others. By type, the market has been further segmented as exocrine pancreas cancer and endocrine pancreas cancer. And by end users as hospitals, clinics, research institutes and others. Futhermore, based on geography the market is segmented into various regions namely Japan, China, India and Australia. Globally North America is the largest market for pancreatic cancer. The prevalence of pancreatic cancer is more in North American countries with U.S. having the highest number of pancreatic cancer patients in the world. Asia-Pacific is anticipated to be the fastest growing region across the globe.

Key players in the pancreatic cancer market include Eli Lilly, Amgen, Inc., Celgene Corp., F. Hoffmann-La Roche, Clovis Oncology Inc., Pfizer, Novartis AG, Threshold Pharmaceuticals Inc., Aduro BioTech Inc., Infinity Pharmaceuticals Inc. and NewLink Genetics Corp.  

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Type of Treatment                  

                                5.1.1 Introduction           

                                5.1.2 Surgery    

                                5.1.3 Chemotherapy     

                                5.1.4 Radiation Therapy

                                5.1.5 Others      

                                5.1.6 Y-o-Y Growth Analysis, By Type of Treatment          

                                5.1.7 Market Attractiveness Analysis, By Type of Treatment         

                                5.1.8 Market Share Analysis, By Type of Treatment          

                5.2 Type                              

                                5.2.1 Introduction           

                                5.2.2 Exocrine Pancreas Cancer

                                5.2.3 Endocrine Pancreas Cancer              

                                5.2.4 Y-o-Y Growth Analysis, By Type      

                                5.2.5 Market Attractiveness Analysis, By Type     

                                5.2.6 Market Share Analysis, By Type      

                5.3 End-users                   

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Clinics        

                                5.3.4 Research Institutes             

                                5.3.5 Others      

                                5.3.6 Y-o-Y Growth Analysis, By End-users            

                                5.3.7 Market Attractiveness Analysis, By End-users          

                                5.3.8 Market Share Analysis, By End-users           

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type of Treatment

                                                6.1.3.3 By Type

                                                6.1.3.4 By End-users

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type of Treatment

                                                6.1.4.3 By Type

                                                6.1.4.4 By End-users

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type of Treatment

                                                6.1.5.3 By Type

                                                6.1.5.4 By End-users

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Eli Lilly                           

                                8.1.1 Overview

                                8.1.2 Type of Product    

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Amgen, Inc.                

                8.3 Celgene Corp.                           

                8.4 F. Hoffmann-La Roche                           

                8.5 Clovis Oncology Inc.                

                8.6 Pfizer                            

                8.7 Novartis AG                

                8.8 Threshold Pharmaceuticals Inc.                          

                8.9 Aduro BioTech Inc.                  

                8.10 Infinity Pharmaceuticals Inc.                             

                8.11 NewLink Genetics Corp.                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Diabetes Care Devices Market By Type of Treatment, From 2016-2021 ( USD Billion )
  2. Asia-Pacific Surgery Market By Region, From 2016-2021 ( USD Billion )
  3. Asia-Pacific Chemotherapy Market By Region, From 2016-2021 ( USD Billion )
  4. Asia-Pacific Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  5. Asia-Pacific Others Market By Region, From 2016-2021 ( USD Billion )
  6. Asia-Pacific Diabetes Care Devices Market By Type, From 2016-2021 ( USD Billion )
  7. Asia-Pacific Exocrine Pancreas Cancer Market By Region, From 2016-2021 ( USD Billion )
  8. Asia-Pacific Endocrine Pancreas Cancer Market By Region, From 2016-2021 ( USD Billion )
  9. Asia-Pacific Diabetes Care Devices Market By End-users, From 2016-2021 ( USD Billion )
  10. Asia-Pacific Hospitals Market By Region, From 2016-2021 ( USD Billion )
  11. Asia-Pacific Clinics Market By Region, From 2016-2021 ( USD Billion )
  12. Asia-Pacific Research Institutes Market By Region, From 2016-2021 ( USD Billion )
  13. Asia-Pacific Others Market By Region, From 2016-2021 ( USD Billion )
  14. Japan Diabetes Care Devices Market By Type of Treatment, From 2016-2021 ( USD Billion )
  15. Japan Diabetes Care Devices Market By Type, From 2016-2021 ( USD Billion )
  16. Japan Diabetes Care Devices Market By End-users, From 2016-2021 ( USD Billion )
  17. China Diabetes Care Devices Market By Type of Treatment, From 2016-2021 ( USD Billion )
  18. China Diabetes Care Devices Market By Type, From 2016-2021 ( USD Billion )
  19. China Diabetes Care Devices Market By End-users, From 2016-2021 ( USD Billion )
  20. India Diabetes Care Devices Market By Type of Treatment, From 2016-2021 ( USD Billion )
  21. India Diabetes Care Devices Market By Type, From 2016-2021 ( USD Billion )
  22. India Diabetes Care Devices Market By End-users, From 2016-2021 ( USD Billion )
Middle East And Africa Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combinatio...
Latin America Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, ...
Asia Pacific Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, H...
Europe Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, Hormona...
North America Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, ...
Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, Hormonal Agent...
Middle East And Africa Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxoru...
Latin America Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Be...
Asia Pacific Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Bev...
Europe Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Bevacizum...
North America Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Be...
Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Bevacizumab, Erl...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.